A Yale University student tested positive for meningitis and in response the college is providing students with a vaccination.
The unidentified student tested positive for the form of meningitis known as serogroup B meningococcal disease, Director Yale Health Dr. Paul Genecin said.
Since the diagnosis, the student is "making excellent progress," Genecin said.
Genecin said one case “does not meet the CDC definition of an outbreak.”
“As soon as meningitis was suspected, we provided preventive antibiotics to anyone who might have had close contact with the student. I am pleased with the response from the Yale community. To date, no additional cases have developed on campus,” Genecin said in a letter on Yale Health website.
According to Connecticut law, all college students must be vaccinated against meningococcal disease. However, the vaccine does not against serogroup B meningococcal disease.
While Genecin said health officials are not recommending a mass vaccination, they are making the vaccination available for anyone interested in the Yale Community.
The new vaccination, which is for people between the ages 18 to 25, requires two inoculations with the second one coming a month after the first one. All vaccines are covered by Yale Health Hospitalization/Specialty coverage for students and Yale Health for employees.
Anyone interested can call Preventive Health at 203-432-0093 to schedule an appointment. If you are older than 25, Genecin said you must call your primary care provider.
For more on meningitis, click here.
To read the full announcement, click here.
Copyright 2016 WFSB (Meredith Corporation). All rights reserved.